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We have isolated a eDNA clone from a mouse brain library encoding the glycine transporter (GLYT), Xenopus oocyt~ injected with a synthetic 
mRNA accumulated [~H]glycine tolevels of up to 80.fold above control values, The uptake was specific for glycia¢ and dependent on the pre~ence 
of Na" and Ci- in the medium. The eDNA sequence predicts a highly hydrophobic protein of 633 amino acids with 12 potential transmembrane 
hellce~, The predicted amino acid sequence has 40--45% identity to the GABA, noradrenaline, s rotonin and dopamine transporters. This implies 
that all of these neurotransmitter transporters may have evolved from a common ancestral gene that diverged into the GABA, glyeiae and 
catecholamine subfamilies at nearly the same time, 
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I. INTRODUCTION 
Synapti¢ transmission involves the release of a trans- 
mitter into the synaptic cleft, interaction with a post- 
synaptic receptor, and subsequent removal of the trans- 
mitter from the cleft [1--4]. The majority of the transmit- 
ters are removed from the cleft by rapid sodium-de- 
pendent uptake systems in the plasma membrane of the 
presynaptie cells. This re-uptake system is catalyzed by 
transporters specific for the various neurotransmitters 
in the brain [5-7]. Amino acids are known to function 
as neurotransmitters in the brain. The most important 
amino acids in this respect are glutamie acid acting as 
a stimulator), neurotransmitter and glyeine which func- 
tions as an inhibitory neurotransmitter. A glycoprotein 
exhibiting sodium and chloride-dependent glycine 
transport activity has been identified and purified from 
brain synaptosomes [8-10]. Recently the purified trans- 
porter was reconstituted into phospholipid vesicles that 
exhibited sodium and chloride-dependent glycine trans- 
port activity [10]. 
The eDNA encoding the GABA transporter was 
cloned, sequenced and expressed in Xenopus oocytes 
[11,12]. Subsequently, other cDNAs encoding neuro- 
transmitter transporters of the catecholamine subfamily 
were cloned and expressed [13-17]. They exhibited sig- 
nificant sequence homology with the GABA trans- 
porter and were highly homologous to each other. In 
this work we report on the cloning and expression of the 
glycine transporter from mouse brain. Its sequence sug- 
gests that this transporter represents a distinct subfam- 
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ily of transporters related to the other two known sub- 
families of GABA and catecholamine transporters. 
2. EXPERIMENTAL 
2,1, Screening the brain eDNA library and sequencing 
A mouse brain 2ZAP eDNA library (Stratagene) was screened 
under low stringency with ~:P-labe.h.~l eDNA encoding a catecholam- 
ine transporter ofbovine adrenal m."dulla ([18] and unpublished), The 
pBluescript was excised from the positive phages and analyzed by dot 
blot and Southern hybridization.~ [19], Synthetic RNA was produced 
from one of the clones and wa~ identified as a 81ycine transporter by 
expression i  Xenopus ooeytes as described previously [11 ]. The eDNA 
of this clone was sequenced by the dideoxy chain termination method 
following serial deletions by e~onuclease III [20,21], Further sequenc- 
ing for verification was performed with synthetic oligonueleotide 
primers, Sequences were aligned and analyzed by DNAstar and GCG 
software packages, 
2,2, Northern blot attalyais 
Mouse brain was dissected to its various parts and RNA was pre- 
pared from the different brain parts as well as from whole brain and 
liver as previously described [19], About 10/.tg of total RNA (5/~g 
from the npinal cord) were applied onto an RNA denaturing agarose 
gel, and following electrophoresis and transfer onto a nylon filter was 
probed by nick translated a-'P-labeled GLYT eDNA, The filter was 
washed at 65°C as previously described [19]. 
2,3. Express'ion i Xenopus ooo'tes 
The synthetic RNA was obtained by transcribing the pBluescript 
containing the GLYT eDNA with an RNA synthesis atad eapging kit 
from Stratagene. Ooeytes were surgically removed from frogs and 
defolliculated by collagenasc treatment, After recovery for 24 h the 
oocytes were inject~l with 50 nl medium containing 2-10 n8 synthetic 
RNA, After two or three days they were asaayed for glycine tramport, 
Prior to uptake assay the oo~tes were preinc.bated for 15 mln in 1 
ml solution containing 100 mM KCi and 10 raM HEPE$ (pH 7,5), The 
transport eaction was initiated by the addition of a solution comain- 
iag 100 mM NaCI, 10 mM HEPES (pH 7.5), about 0.1 /~Ci of 
[~H]81ycino and the specified amounts of cold glycine. At the end of 
a 45-rain incubation period, the ooeytes were washed three times with 
1.5 ml of the same buffer in which the radioactive glycine was ex-  
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eluded. Individual oocytes were solubilizcd in 50/al of 10% SDS, and 
the radioactivity, was measured b~, scintillation counting. Five ooeytes 
were a~d for each experimental point and the data are expressed as
the average uptake per hour. 
3, RESULTS 
The clone encoding the gb, cine transporter was iso- 
lated from a mouse brain eDNA library by hybridiza- 
tion with ~-'P-labeled eDNA encoding a catecholamine 
transporter cloned from a bovine adrenal ibrary ([18] 
and unpublished ata). Over forty clones were collected 
and one was determined to contain the glycine trans- 
porter by expression i  Xenopus oocytes. The c!one con- 
tains a eDNA insert of 3.2 kb with an open reading 
frame of 1,899 bp. The region of the first ATe  resem- 
bles the consensus equence described by Kozak [22] 
and was assigned as the putative translation initiation 
site. The sequence predicts a protein of 633 amino acids 
with a molecular mass of 70,785 (71 kDa) that is some- 
what larger than the GABA and cateeholamine trans- 
porters [11-17]. Hydrophobieity analysis is superimpos- 
able with that of the other transporters, and reveals 12 
potential hydrophobie ~gments that could form trans. 
membrane domains. Therefore, the tentative structural 
model of  the glycine transporter is similar to the pro- 
posed membrane topologies of the GABA and eatechol. 
amine transporters [11,13]. The external loop after the 
third transmembrane helix contains 9 and 20 more 
amino acids than the noradrenalinc and GABA trans- 
porters, respectively (Fig. 1). It also contains an addi- 
tional putative glycosylation site to tho~e of the GABA 
and noradrenaline transporters. 
The amino acid sequence of the glycine transporter 
is 45, 43, 40 and 42% identical to the respective amino 
acid ,~equenees of the GABA, noradrenaline, dopamine 
and .~ero:onin transporters [11-17]. The three catechol- 
amine transporters are highly homologous among 
themselves. Therefore it is likely that the slyeine, GABA 









ECSLGQYTSlGGLGVH~LAPMFKGVGL~AAVLSFHLHIYYIVIISHA~YYLYNS?T~TLPHK~DNgNNTDBC .................. FSNYS-MV~t- 
t R ; t t ; ; t  • t t t t ; | : l l t l t t t  : t : l  : e* !  i : l  a~ l~: : :}  i ~11 t : t~t~ I : I  • : • 
~L~G~F^~GCLG~$~M~G~GYGMM%~VSTY~G~¥Y~Ic~A~MT"V~HAYcN~NT~D~AG~LDA~NL~NG~R~AAL~GNLSBLF~Y 








~: t~ I t l : l l l : t  t ~ t : l t : : l~ l l  ~ l~ l  ** t t : t :  ~ t : : t t t l t t t l~ l . t t ;  ; :  t t  t . t t l l : l t l t l : t  t t t~ l~ i :  
~AKvW~DBAs~I~Y~LGcAWGGL~T~Y~?HNNcYRD~T~cATRLYA~Fv~ILGrMANHLGVD~RVAD~GPG~d~AYF~ALT~s~L~ 















Fig. 1. The amino acid sequene~ of the mourn glycine transporter align¢~! with the human GABA and noradrenaliae tramporter~. The amino acid 
sequence ofthe mouse glycine transporter (GLYT) was deduced from the eDNA s~.-luenee of the cloned gone (to be dispo~d in GencBank). The 
amino acid sequences of the human GABA translmrter (GABAT) [12] and noradrenaline transporter (NET) [13] were previously published, 
Identical amino acids are indicat~ by (*) and conservative ami~:o acid replacements by (:). Putative transmembrane domains are underlined. 
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branched out from a co u~non ancestral gene at approx- 
imately the same time. The sequence comparisons of 
these three subfamilies also open up a new avenue of 
research toward the definition of the various binding 
sites in the different transporters which may lead Io a 
better understanding of their mechanism of action. 
Xenopus oocytes injected with GLYT synthetic RNA 
accumulated up to 80 times as much glycine as water- 
injected oocytes, uninjeeted ooeytes, or ooeytes injected 
with OABA-transporter RNA. Transport of other 
amino acids such as alanine, serine, thrconine, praline, 
tyrosine, valine, isoleucine, phcnylalanin¢, aspartic 
acid, glutamic acid and GABA could not be detected 
and cold amino acids (¢xccpt for glycine) or betaine at 
100/~M concentration did not inhibit glyoin¢ transport. 
Sarcosin¢ inhibited glycin¢ uptake with a K~ of about 50 
gM (not shown). Fig. 2 shows the rate of [~H]glycin¢ 
uptake into Xenopus oocytes injected with a synthetic 
mRNA of the glycine transporter at various glyeine 
concentrations. The Eadie-Hofstec plot revealed a 
Michaelis constant (Kin) of2S/~M, and two other exp¢r- 
imcnts gave Km values of 18 and 20 ItM. The mean value 
of about 20/~M is within the range of values reported 
for the affinity ofglycin¢ uptake in brain [I0]. Thus the 
affinity of the brain glycin¢ transporter is about 80-fold 
higher than the liver transporter and exhibits a much 
higher specificity to glycine [23]. It was reported that 
glyeine transport in brain slices and in sohbilized and 
reconstituted membrane vesicles is dependent on a Na  ~ 
gradient and the presence of chloride in the external 
medium [8-I0]. In the GLYT-RNA injected oocytcs the 
glyein¢ uptake was absolutely dependent on the electro- 
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Fig. 2. Effcot of glycine concentrations  glycine uptake into Xcnopus 
oocytcs injected with mRiNA transcribed from GLYT eDNA. 
[~HlGly¢in~ uptake was assayed as described in section 2, with 
mRNA-inj¢cted and -uninjgcted cocytcs at room temperature for 4fi 
rain. The values obtained with uninjectcd oocytes were subtracted 
from the corresponding inj¢¢tcci samples. Eadie-Hofstec analysis is 
d~scribcd in the insert of the figure. 
chemical gradient of sodium (Fig. 3). Potassium, lith- 
ium and choline were inactive as cation replaosment. 
Glycine uptake was also dependent on the presence of 
specific anions. Chloride was the most effective and 
gluconat¢ was less than 5% as effective as chloride. On  
the other hand, nitrate supported about 25% of the 
activity obtained with chloride. Glyein¢ uptake at vari- 
ous chloride concentrations revealed that about 23 mM 
of the anion we~'c required for half maximal activity of 
the transporter (Fig. 4). 
In contrast with the other transporters little is known 
of the location and pharmacology of the glycine trans- 
porter. Due to its high affinity to strychnine, the strych. 
nine-sensitive glycine receptor provided the bulk of the 
data on neurotransmission by glycine [24-26]. Northern 
blot with cDNA encoding the strychnine binding sub- 
unit of the glycine receptor revealed its presence in the 
spinal cord and brainstem but not in the cerebellum 
[27]. Northern blot analysis of RNA from different 
parts of the mouse brain with labeled eDNA encoding 
the glycine transporter gave strong signals with cerebel- 
lum, medulla, pans, spinal cord, and weak signals with 
frontal cortex and whole brain (Fig. 5). A related tran- 
script was also identified in the kidney and to a lesser 
extent in the liver (not shown). There is an apparent 








Fig. 3. Effect of various anions and cations on 81y¢inc uptake by 
GLYT  mRNA-injcctcd Xcn@u# oocytcs. Oocytcs were prepared and 
assayed as described in the legend to Fig, 2 except that the ,~ssay buffer 
was changed according to the different ions test~. For ).he azsay of 
cations ?qaCl was replaced by 100 mM of KCl, LiCI or choline chlo- 
ride durin8 the uptake period. During the preincubation, ibr the var- 
ious anions, the 100 mM KCI was substituted with 100 mM potassium 
gluconatc, and for the uptake medium the NaCl was rcplac.cd by 
sodium gluconat¢ or sodium nitrate. The l~lycin¢ concentration was 
2/~H in all the assays. 
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Fig. 4. Effect of chloride concentrations on glycine uptake by GLYT mRNA-injeeted ,Yenapus oo~y~es. Oocytes w0re prepared and assayed a.s 
described in the legend to Fig. 2 except hat 100 ram sodium glueonate r placed the NaCI. The indicated amounts of NaCl were added to the a~sa)' 
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Fig. 5. Localization of glyeine transporter mRNA in various tissues. 
Northern hybridization was pcrform~l asd¢'seribed in s~'etion 2.The 
size of the hybridized RNA was determined by ~¢eond hybridization 
with ladled eDNA of GABA transporter (4.2 kb) [11,12], the bovine 
adrenal proteolipid [12,40] and molecular weight standards. The 
source of the RNA was: (1) whole brain, (2) cerebellum, (3) frontal 
cortex, (4) medulla, (5) thalamus, (6) pens, (7) spinal cord, (8) liver. 
in the cerebellum and the strong signal obtained with 
the glycine transporter DNA. This can be due to the 
transporter functioning in the cerebellum in another 
system that does not involve the strychnine sensitive 
glycine receptor. Recently, a new role for glycine in 
allosteric regulation of the NMDA receptor has been 
proposed [28]. This will require a glycine uptake system 
in brain parts that do not contain the strychnine sensi- 
tive glycine receptor. Alternatively the eDNA of the 
glycine transporter may hybridize with a closely related 
transporter (e.g. the glutamate transporter) that could 
be present in high amounts in the cerebellum. This ob- 
stacle of Northern hybridization applies to all other 
Northern analyses performed with the other neuro- 
transmitter t ansporters. 
4. DISCUSSION 
Neurc~transmitter ransporters are a vital part of 
brain neurotransmission. They are present not only in 
the presynaptic terminals but also in glial cells where 
they function in the removal of the transmitters that 
escaped the synaptic clefts [29,30]. However, every 
transporter is highly specific to the neurotransmitter it 
transports across the membrane. The cloning of the 
eDNA encoding the GABA transporter [11,12], and 
• later the catecholamine transporters [13] have defined 
a novel family of membrane transporters. The cloning 
of the glycine transporter reported in this work ex- 
tended the family to amino acid neurotransmitters. 
Only recently cDNAs encoding amino acid transporters 
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in mammalian cells were cloned and sequenced [31-33]. 
Analysis of the transport activity of an eetopic mouse 
retrovirus receptor evealed that the original activity of 
the protein was a transport of cationic amino acids 
across plasma membranes [31,32]. This transporter con- 
tained 14 putative transmembrane h lices and may be 
related to arginine and histidine permeases of Saccharo- 
myces cerevisiae [34,35]. Very recently the first neutral 
amino acid transporter was cloned from a rat kidney 
eDNA library [33]. It encodes aprotein of about 70 kDa 
with a potential 4 transmembrane h lices. Expression in 
Xenopus oocytes revealed that it transports a variety of 
neutral amino acids. 
The glycine transporter is highly specific for glycine 
and will not transport any other amino acid. Even alan- 
ine that is structurally closest o glycine is not taken up 
by GLYT mRNA-injected oocytes, Moreover, all the 
amino acids tested id not inhibit glycine transport into 
the mgNA-injected oocytes. Recently we cloned more 
than ten genomic and eDNA clones encoding proteins 
of the neurotransmitter-transporter gone family. We 
estimate that there are more than fifty different rans- 
porters functioning in mammalian brain. A search in 
the GenBank also revealed two related genes of Droso- 
phila melanogaster and C. elegance. Therefore the fam- 
ily ofneurotransmitter ransporter genes is rooted in the 
early development of the nervous ystem and its speci- 
ficity may define specific brain functions. 
The cloning and expression of a glycir, e transporter 
may provide an opportunity to look for specific phar- 
macological substances affecting the glycine re-uptake 
system. Glycine receptors were implicated in the patho- 
genesis of spasticity [36,37] and the loss of motor con- 
trol associated with different human diseases [38,39]. 
The study of a cloned glycine transporter may comple- 
ment the search for a cure of these diseases. 
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